French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps was informed on 07/08/09 of a withdrawal of lots of reagent Arthri-Sidex made by Biomérieux following a performance defect. The users of this device concerned by this defect, in France, have received the attached letter (12/08/2009) (27 KB). The competent European authorities have been informed of this measure by (manufacturer or Afssaps). This information is intended for laboratory managers, directors of health establishments and local correspondents of reactive vigilance for distribution to the concerned biology departments.
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
In agreement with the Afssaps, the company Biomérieux, informed, on 20/11/2009, the users of the ChromID Salmonella reagent of the withdrawal of a batch following a problem of sensitivity. The users of this device concerned by this defect, in France, received the attached mail (23/11/2009) (26 KB). The competent European authorities have been informed of this measure by the manufacturer. This information is intended for laboratory managers, directors of health establishments and local correspondents of reactive vigilance for distribution to the concerned biology departments.
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps has been informed of the implementation of a recall of 2 batches made by Biomérieux .. The users concerned have received the enclosed letters (30/06/2011) (79 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps was informed on 25/03/10 of a withdrawal of lots of TPHA 100 reagent made by Biomérieux on 29/03/10. The users of this device concerned by this defect, in France, have received the attached letter (02/04/2010) (48 KB). The competent European authorities have been informed of this measure by the manufacturer. This information is intended for laboratory managers, directors of health establishments and local correspondents of reactive vigilance for distribution to the concerned biology departments.
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Afssaps was informed on 15/07/2010 of the implementation of a security action carried out by Biomérieux .. The users concerned received the attached mail (23/07/2010) (49 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Afssaps was informed on 30/08/2010 of the implementation of a lot recall carried out by the company BIOMERIEUX .. The users concerned received the attached mail. (09/09/2010) (53 KB)
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps was informed on 30/07/2010 of the implementation of a batch recall carried out by Biomerieux SA. The users concerned have received the attached mail (09/08/2010) (49 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps was informed on 17.01.11 of the implementation of a recall of a batch made by Biomérieux. The affected users received the attached mail (24/01/2011) (43 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps has been informed of the implementation of a recall made by Biomérieux. The affected users have received the attached mail (30/03/2011) (39 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps has been informed of the implementation of a lot recall made by Biomérieux .. The users concerned have received the attached mail (07/07/2011) (95 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps has been informed of the recall of two batches made by BIOMERIEUX. The affected users have received the attached mail (14/10/2011) (71 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Agency has been informed of the implementation of the recall of a batch carried out by Biomérieux. The affected users have received the attached mail (08/11/2011) (29 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Agency has been informed of the implementation of a recall made by Biomérieux. The affected users have received the attached mail (08/11/2011) (35 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Agency has been informed by the Biomérieux company of the discontinuation of the Slidex Staph Plus reagents, references 73115 and 73116. The users concerned have received the attached mail (08/11/2011) (36 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Agency has been informed of the implementation of a recall of 3 batches of reagents carried out by BioMérieux. The users concerned have received the attached mail (15/11/2011) (50 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Afssaps was informed on 6/12/2011 of the implementation of a recall of batches made by Biomérieux .. The users concerned received the attached mail (14/12/2011) (32 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps was informed on 23.12.2010 of a recall made by the company. The users concerned have received the attached mail (10/01/2011) (19 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps has been informed of the implementation of a recall made by Biomérieux .. The users concerned have received the attached mail. (25/01/2012) (252 KB)
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Afssaps has been informed of the implementation of a recall made by Biomérieux. The users concerned have received the attached mail (12/03/2012) (23 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The Agency has been informed of a recall of a batch made by Biomérieux. The users concerned have received the attached mail (03/05/2012) (54 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The company BioMérieux informed the users of the reagent Vidas EBV VCA / EA IgG of the implementation of the recall of two batches. The users concerned, in France, received the attached mail (09/07/2012) (60 KB ). This information is addressed to the directors of health establishments and local correspondents of reactovigilance for diffusion to the concerned services.
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
BIOMERIEUX has informed users of the chromID Strepto B Agar (STRB) reagent for the withdrawal of a lot. The users concerned, in France, received the attached mail. (23/10/2012) (431 KB). This information is addressed to the directors of health establishments, medical biologists and local correspondents of reactovigilance for diffusion to the concerned services.
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
Biomérieux has informed users of the Vidas D-Dimer Exclusion II test of the withdrawal of a lot. The users concerned, in France, received the attached mail (11/01/2013) (87 KB). This information is addressed to the directors of health establishments and local correspondents of reactovigilance for diffusion to the concerned services.
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
ANSM has been informed of the implementation of the recall of a batch made by Biomérieux. The users concerned have received the attached mail (14/01/2013) (86 KB).
French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
Notes supplémentaires dans les données
Action
The ANSM has been informed of the implementation of a recall made by the company Biomérieux .. The users concerned have received the attached mail (15/01/2013) (73 KB).